N-terminal pro B-type natriuretic peptide (NT-proBNP): a possible surrogate of biological age in the elderly people

被引:0
|
作者
Antonio Muscari
Giampaolo Bianchi
Paola Forti
Donatella Magalotti
Paolo Pandolfi
Marco Zoli
机构
[1] University of Bologna-S.Orsola-Malpighi Hospital,Department of Medical and Surgical Sciences
[2] S.Orsola-Malpighi Hospital,Medical Department of Continuity of Care and Disability
[3] AUSL Bologna,Epidemiological and Health Promotion Unit, Department of Public Health
来源
GeroScience | 2021年 / 43卷
关键词
NT-proBNP; Mortality; Biological age; Epidemiological studies;
D O I
暂无
中图分类号
学科分类号
摘要
NT-proB-type natriuretic peptide (NT-proBNP) increases with age and is associated with all-cause mortality. With this study, we assessed its possible utilization as a marker of biological age in comparison with other variables. The study included 1079 non-institutionalized elderly subjects (mean age 72.8 ± 5.5 years, 561 women). Baseline measurements were performed of serum NT-proBNP and of some laboratory variables previously utilized to estimate biological age (creatinine, albumin, C-reactive protein, cholesterol, blood glucose, leukocytes, lymphocytes, hemoglobin, mean cell volume). During 7 years of follow-up, 114 all-cause deaths occurred. The logarithm of NT-proBNP was the most age-related parameter (r = 0.35, P < 0.0001). Its relationship with mortality, according to Cox regression and ROC curve (AUC = 0.707, 95% CI 0.654–0.759), was stronger than that of all other variables, including age. In multivariate analysis, only NT-proBNP and age remained independently associated with mortality. The regression lines between age and NT-proBNP (pg/ml) allowed a separate estimation of biological age (“proBNPage”) for men (= [log(NT-proBNP) + 1.2068]/0.0827) and for women (= [log(NT-proBNP) − 1.5258]/0.0478). The hazard ratio of all-cause mortality for the fifth quintile of proBNP age (≥ 85 years) compared with the first quintile (< 61 years) was 7.9 (95% CI 3.6–17.5). Similarly, the difference between pro-BNPage and chronological age was associated with a hazard ratio of 3.5 in the fifth quintile (95% CI 1.9–6.4) and was associated with disease count (P for trend = 0.0002). In conclusion, NT-proBNP was the best indicator of biological age, which can be estimated by simple formulas and might be used for prognostic purposes or as a surrogate end point in epidemiological and intervention studies.
引用
收藏
页码:845 / 857
页数:12
相关论文
共 50 条
  • [31] A NOVEL PATHWAY TO AN ELEVATED N-TERMINAL PROHORMONE-B-TYPE NATRIURETIC PEPTIDE (NT-proBNP)
    Messele, L. F.
    Jimenez, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (01) : NP353 - NP353
  • [32] Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland - The PolSenior Study
    Nadrowski, P.
    Chudek, J.
    Grodzicki, T.
    Mossakowska, M.
    Skrzypek, M.
    Wiecek, A.
    Zdrojewski, T.
    Kozakiewicz, K.
    EXPERIMENTAL GERONTOLOGY, 2013, 48 (09) : 852 - 857
  • [33] Brain natriuretic peptide (BNP) and N-terminal proBNP (nt-proBNP) in haemodialysis patients
    Racek, J
    Kralova, H
    Eiselt, J
    Trefil, L
    Rajdl, D
    Jerabek, Z
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V297 - V297
  • [34] Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort
    Welsh, Paul
    Campbell, Ross T.
    Mooney, Leanne
    Kimenai, Dorien M.
    Hayward, Caroline
    Campbell, Archie
    Porteous, David
    Mills, Nicholas L.
    Lang, Ninian N.
    Petrie, Mark C.
    Januzzi, James L.
    McMurray, John J., V
    Sattar, Naveed
    CIRCULATION-HEART FAILURE, 2022, 15 (10) : E009427
  • [35] Longitudinal changes of N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) and total mortality in elderly people: the ActiFE Study.
    Dallmeier, D.
    Braisch, U.
    Koenig, W.
    Denkinger, M.
    Rothenbacher, D.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2017, 50 : S122 - S122
  • [36] Relationship between N-terminal pro-B-type natriuretic peptide (Nt-proBNP) and cardiac cycle efficiency in cardiac surgery
    Scolletta, S.
    Ranaldi, G.
    Carlucci, F.
    Franchi, F.
    Romano, S. M.
    Biagioli, B.
    BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (08) : 511 - 515
  • [37] Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure With Preserved Ejection Fraction
    Azzo, Joe David
    Dib, Marie-Joe
    Zagkos, Loukas
    Zhao, Lei
    Wang, Zhaoqing
    Chang, Ching-Pin
    Ebert, Christina
    Salman, Oday
    Gan, Sushrima
    Zamani, Payman
    Cohen, Jordana B.
    van Empel, Vanessa
    Richards, A. Mark
    Javaheri, Ali
    Mann, Douglas L.
    Rietzschel, Ernst R.
    Schafer, Peter H.
    Seiffert, Dietmar A.
    Gill, Dipender
    Burgess, Stephen
    Ramirez-Valle, Francisco
    Gordon, David A.
    Cappola, Thomas P.
    Chirinos, Julio A.
    CIRCULATION-HEART FAILURE, 2024, 17 (02) : E011146
  • [38] N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction
    Kim, Ji-Youn
    Lee, Eun Young
    Jee, Jae-Hwan
    Lee, Byung-Wan
    Chung, Jae Hoon
    Jeun, Eun Suk
    Min, Yong-Ki
    Lee, Myung-Shik
    Kim, Kwang-Won
    Lee, Moon-Kyu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 77 : S238 - S242
  • [39] Assessment of B-type natriuretic peptide (BNP) and N-terminal (NT)-proBNP in hypertensive patients with heart failure
    Degli Esposti, D
    Veronesi, M
    Cosentino, E
    Dormi, A
    Bacchelli, S
    Maione, D
    Prandin, MG
    Borghi, C
    Ambrosioni, E
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 81A - 82A
  • [40] Diagnostic importance of N-terminal pro brain natriuretic peptide (NT-proBNP) in peripheral vascular disease
    Salmayenli, N
    Basar, Y
    Aksoy, M
    Ayalp, K
    Serin, K
    Sivas, A
    Baktiroglu, S
    CLINICA CHIMICA ACTA, 2005, 355 : S104 - S104